BIO Establishes Principles For Follow-on Biologics To Guide Lawmakers
This article was originally published in The Pink Sheet Daily
Executive Summary
In letters sent to legislators, BIO asks Congress to adopt the principles, emphasizing patient health and biotech innovation.
You may also be interested in...
PDUFA Bill Moves To Senate Mark-Up, But Without Generic Biologics Language
April 18 session is planned in the HELP Committee as advocates for follow-on pathway continue to press their case.
PDUFA Bill Moves To Senate Mark-Up, But Without Generic Biologics Language
April 18 session is planned in the HELP Committee as advocates for follow-on pathway continue to press their case.
Exclusivity For Biologics Should Potentially Be Longer Than For Small Molecule Drugs – BIO Exec
In debate over follow-on biologics pathway, BIO and GPhA agree on little except the need to lay out intellectual property ground rules.